Ontology highlight
ABSTRACT:
SUBMITTER: Chrvala CA
PROVIDER: S-EPMC3474424 | biostudies-other | 2012 Aug
REPOSITORIES: biostudies-other
P & T : a peer-reviewed journal for formulary management 20120801 8
Four recently approved drugs (cabazitaxel, sipuleucel-T, abiraterone, and denosumab), along with emerging therapies, bone-building therapies, hormonal treatments, and immunotherapies, have all demonstrated promise in advanced prostate cancer. It appears that the best outcomes will be achieved from the sequential use of multiple agents. ...[more]